Intraductal Papilloma

Intraductal papilloma is a benign, papillary epithelial proliferation arising within a breast duct. It is the commonest cause of unilateral, spontaneous, blood-stained or serous nipple discharge from a single duct.

It occurs either as a solitary lesion or as multiple lesions. A solitary lesion typically arises within a large, central subareolar duct, and generally carries minimal or no increased breast cancer risk.

Multiple lesions more typically arise within smaller, peripheral ducts. They carry a modestly increased longer-term breast cancer risk, particularly with atypical epithelial features on histology.

Careful evaluation is essential. Blood-stained discharge is a sometimes alarming symptom, and cancer risk differs between the solitary and multiple lesion patterns.

Pathophysiology and classification

• Solitary intraductal papilloma typically arises within a large, central, subareolar duct. It is a benign, papillary proliferation of ductal epithelial cells supported by a fibrovascular core.
• The bloody or serous nipple discharge reflects the fragile, friable nature of the lesion and its propensity for minor, spontaneous bleeding. In some cases there is also ductal obstruction.
• Multiple peripheral papillomas typically arise within smaller, more peripheral ducts. Their distal location makes nipple discharge less consistent.
• They more commonly present as a palpable mass or, increasingly, as an incidental finding on screening mammography. This pattern carries a modestly increased association with subsequent breast cancer risk, particularly where atypical histological features are identified.
• Papillary lesions can, in a small proportion of cases, harbour or be closely associated with atypical hyperplasia or, less commonly, ductal carcinoma in situ. Full histological assessment of any papillary lesion is therefore essential to characterise its nature and associated risk.

• Unilateral, spontaneous nipple discharge from a single duct, typically blood-stained or serous in character, represents the classic, characteristic presenting feature of solitary intraductal papilloma, often intermittent in nature and, in some cases, precipitated or exacerbated by gentle pressure over the specific, affected subareolar region.
• A small, sometimes barely palpable subareolar mass may be present, corresponding to the location of the underlying papillary lesion, though the lesion is frequently too small to be reliably palpated on clinical examination alone, with the presenting discharge frequently representing the sole clinical manifestation.
• Multiple peripheral papillomas more typically present as a palpable mass or an incidental imaging finding, with associated nipple discharge occurring less consistently compared with the solitary, central lesion pattern.
• The presenting nipple discharge, particularly when blood-stained, frequently generates significant patient anxiety given the understandable concern regarding possible underlying malignancy, underscoring the importance of prompt, full evaluation and clear, sensitive communication throughout the diagnostic process.

• The essential initial approach is clinical assessment, with careful examination to identify the causative duct by gentle, systematic compression around the areolar margin.
• Ultrasound is a valuable, sensitive investigation for identifying an intraductal lesion, particularly when combined with ductal dilation.
• Mammography gives further, complementary information. In some centres, ductography adds to it: contrast is injected into the affected duct to outline any intraductal filling defect directly.
• Core needle biopsy or, more definitively, surgical excision is generally required to confirm the histological nature of an identified lesion and to exclude any associated atypia or malignancy.
• Papillary lesions can harbour or coexist with atypical hyperplasia or in situ malignancy. Core needle biopsy alone is limited in reliably excluding this, because the architectural complexity of these lesions makes sampling less reliable than for other lesion types.
• Surgical excision is therefore frequently recommended for definitive histological characterisation of any biopsy-confirmed papillary lesion, rather than relying on core biopsy findings alone.

• Surgical excision is the standard management. For a solitary, central lesion associated with nipple discharge this is typically microdochectomy, removing the affected duct together with the papillary lesion.
• Excision gives definitive symptomatic relief from the discharge. It also allows histological examination of the entire lesion to exclude any associated atypia or malignancy that might not have been adequately represented on a preceding core needle biopsy sample alone.
• Multiple peripheral papillomas carry a modestly increased breast cancer risk, particularly with atypical histological features. They warrant careful, individualised discussion of surgical excision and, in some cases, enhanced longer-term breast cancer surveillance, following specialist assessment and counselling.
• After excision confirming a benign papilloma without atypia, no additional treatment or enhanced surveillance is generally required beyond routine, age-appropriate breast screening. The excision is considered definitive, curative treatment.
• Where excision reveals associated atypical hyperplasia or in situ malignancy, management follows the principles for the corresponding condition (including lobular carcinoma in situ or breast cancer, according to the histological findings).
• Patient education, clear and sensitive communication, and reassurance about the generally excellent prognosis once appropriately treated underpin management of this common cause of pathological nipple discharge.